Individuals Coming Off Slimming Jabs Regain Weight at a Quadrupled Rate Compared to People Using Diet and Exercise

A recent study suggests that patients who discontinue blockbuster weight-loss injections like Wegovy and Mounjaro can put back on lost weight far faster than those who end traditional lifestyle programs.

Published data in a prominent medical journal points out that while obese people frequently drop about a fifth of their body weight while undergoing treatment, the mass returns at an average rate of 0.8 kg per month upon discontinuation.

"Individuals buying such drugs need to be cognizant of the potential of quick weight regain when the therapy ends," cautioned lead investigator Dr. Susan Jebb.

Such speed of recovery suggests a return to original mass within about a year and a half.

Weighing Therapies

The analysis, which reviewed dozens of studies involving thousands of patients, compared the effects of the injectable medications with other pills.

Researchers note that people who shed pounds through dieting typically have a less rapid creep back—perhaps 0.1 kg a month—once they finish.

Explaining the Fast Regain

Experts suggest the mode of action of the jabs is key to understanding the amplified regain.

These medications copy a natural hormone called GLP-1, which controls appetite.

"Long-term administration of GLP-1 concentrations several times higher than normal may cause the body to generate a reduced amount of its endogenous hormone, and may also diminish responsiveness to its actions," noted Dr. Adam Collins, a nutrition specialist.

"Stopping of this hormone supplement means appetite is uncontrolled, making binge eating much more probable."

A Lifelong Issue?

Medical guidelines recommend the injections for people with weight-linked medical conditions, alongside recommended diet and exercise modifications.

Many experts argue that, given the significant potential of relapse, the treatment should be considered life-long.

This view is supported by drug manufacturers, who state that the findings "underscore the persistent character of obesity," similar to managing conditions like diabetes.

User Experiences

People who have stopped the medication report a sudden resurgence of cravings.

"I experienced something that goes on and I was suddenly extremely hungry," recalled an individual.

This difficulty is worsened if patients have not established sustainable lifestyle or habit changes during therapy.

Significant Interest

Survey data suggest that a significant number of adults in the UK have tried weight-loss jabs in the past year, with desire being substantial.

• Use is greater among women compared to males.
• The middle-aged demographic shows the greatest level of interest.
• A large proportion obtain the drugs through private prescriptions rather than public health services.

In conclusion, clinicians caution that while these medications are potent tools for shedding pounds, they are not a magic cure and long-term success likely depends on ongoing behavioural changes.